(Q54562217)

1 June 2018

title

Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. (English)

1 reference

1 June 2018

author name string

Chin-Chuan Hung

1

1 reference

1 June 2018

Mu-Han Chiou

2

1 reference

1 June 2018

Bo-Hau Huang

3

1 reference

1 June 2018

Yow-Wen Hsieh

4

1 reference

1 June 2018

Tsung-Jen Hsieh

5

1 reference

1 June 2018

Chieh-Liang Huang

6

1 reference

1 June 2018

Hsien-Yuan Lane

7

1 reference

1 June 2018

publication date

8 September 2011

1 reference

1 June 2018

published in

Pharmacogenomics

1 reference

1 June 2018

volume

12

1 reference

1 June 2018

issue

11

1 reference

1 June 2018

page(s)

1525-1533

1 reference

1 June 2018

History and current status of opioid maintenance treatments: blending conference session

cites work

1 reference

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments

21 January 2018

1 reference

In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites.

21 January 2018

1 reference

Variable modulation of opioid brain uptake by P-glycoprotein in mice

21 January 2018

1 reference

Implications of genetic polymorphisms in drug transporters for pharmacotherapy

21 January 2018

1 reference

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene.

21 January 2018

1 reference

ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals

21 January 2018

1 reference

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

21 January 2018

1 reference

How individual sensitivity to opiates can be predicted by gene analyses

21 January 2018

1 reference

Are mu-opioid receptor polymorphisms important for clinical opioid therapy?

21 January 2018

1 reference

Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers

21 January 2018

1 reference

The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers

21 January 2018

1 reference

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease

21 January 2018

1 reference

Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?

21 January 2018

1 reference

Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.

21 January 2018

1 reference

Interindividual variability of methadone response: impact of genetic polymorphism

21 January 2018

1 reference

Mammalian G proteins and their cell type specific functions

21 January 2018

1 reference

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene

21 January 2018

1 reference

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

21 January 2018

1 reference

Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence.

21 January 2018

1 reference

Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment

21 January 2018

1 reference

DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

21 January 2018

1 reference

Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution

21 January 2018

1 reference

The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment

21 January 2018

1 reference

Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments

21 January 2018

1 reference

Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method

21 January 2018

1 reference

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation

21 January 2018

1 reference

The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans

21 January 2018

1 reference

Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs

21 January 2018

1 reference

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 January 2018

1 reference

Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.

21 January 2018

1 reference

Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey

21 January 2018

1 reference

OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths

21 January 2018

1 reference

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia

21 January 2018

1 reference

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers

21 January 2018

1 reference

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

21 January 2018

1 reference

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis

21 January 2018

1 reference

Pharmacogenetics of opioid receptors and addiction

21 January 2018

1 reference

Association study of candidate genes for the prevalence and progression of knee osteoarthritis

21 January 2018

1 reference

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

21 January 2018

1 reference

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment

21 January 2018

1 reference

ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach

21 January 2018

1 reference

Statistical design and analysis of pharmacogenetic trials

21 January 2018

1 reference

Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach

21 January 2018

1 reference

Stereoselective Block of hERG Channel by (S)-Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.11.96

1 reference

1 June 2018

PubMed ID

21902500

1 reference

1 June 2018